文献速递肥胖与代谢综合征

基于BMI识别未正式诊断肥胖患者的临床过程指标开发与验证

Development and Validation of a Measure Identifying Patients With Obesity by BMI Without an Official Diagnosis.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

本研究开发并验证了一种临床过程指标,用于识别电子健康记录问题列表中缺乏正式肥胖诊断但BMI达到肥胖标准的患者。

要点

  • 该指标可系统识别EHR中未记录肥胖诊断的BMI肥胖患者。
  • 有肥胖诊断记录的患者更可能减重,支持指标的预测效度。
  • 指标信度高,易于在电子健康记录中实施。

核心结论

  • 实施该EHR指标可促进系统化肥胖管理,将肥胖识别整合到常规临床实践中。

研究设计与样本

  • 研究开发并验证了一种基于EHR的临床过程指标,在6个医疗组(124家诊所,3483名提供者)进行试点测试。
  • 采用β-二项模型评估诊所和提供者层面的信度,通过比较有和无肥胖诊断患者1年体重变化评估预测效度。

主要发现

  • 信度高:诊所级0.97,提供者级0.89。

临床怎么用

  • 可将该指标嵌入EHR系统,系统识别BMI肥胖但无正式诊断的患者,提示医生记录诊断并启动干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Obesity is a chronic disease with significant health risks that remains underdiagnosed in clinical settings. This study developed and validated a clinical process measure to identify patients with obesity, defined by body mass index, who lack a formal diagnosis in their electronic health record (EHR) problem list. METHODS: The measure was pilot-tested across 6 medical groups (124 clinics, 3483 providers). Reliability was assessed at the clinic and provider levels using the β-binomial model. Predictive validity was evaluated by comparing 1-year weight change in patients with and without an obesity diagnosis. RESULTS: Across 6 participating medical groups, a total of 295 372 eligible patients were identified between January 1 and December 31, 2022. Obesity diagnosis rates ranged from 37.6% to 50.8%. In a predictive cohort of 1132 patients with at least 1 follow-up weight recorded within the year following the index visit, those with a documented obesity diagnosis lost an average of 0.34 pounds, whereas those without gained 1.78 pounds (P = .026). Reliability was high (clinic-level: 0.97; provider-level: 0.89), demonstrating consistent performance. DISCUSSION: Findings highlight the clinical importance of documenting obesity in the EHR. Patients with an obesity diagnosis were more likely to lose weight, supporting the measure's predictive validity. This measure addresses gaps in obesity care, promoting early identification, targeted interventions, and better outcomes. Its feasibility as an EHR-based measure enhances adaptability across healthcare settings. CONCLUSION: Implementing this measure can facilitate systematic obesity management, align with public health priorities, and improve patient care by integrating obesity recognition into routine clinical practice.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Mahon LR, Bianco J, Xiong M, et al. Development and Validation of a Measure Identifying Patients With Obesity by BMI Without an Official Diagnosis. J Clin Endocrinol Metab. 2026. PMID: 40826492. doi:10.1210/clinem/dgaf464

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。